True Vision MN LLC Invests $661,000 in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) (2024)

True Vision MN LLC purchased a new position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 25,307 shares of the pharmacy operator’s stock, valued at approximately $661,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Fulton Bank N.A. boosted its holdings in Walgreens Boots Alliance by 0.5% in the fourth quarter. Fulton Bank N.A. now owns 107,071 shares of the pharmacy operator’s stock valued at $2,796,000 after acquiring an additional 523 shares during the last quarter. Insight Folios Inc lifted its stake in Walgreens Boots Alliance by 5.8% in the fourth quarter. Insight Folios Inc now owns 9,640 shares of the pharmacy operator’s stock valued at $252,000 after buying an additional 525 shares during the period. Pinnacle Financial Partners Inc lifted its stake in Walgreens Boots Alliance by 4.9% in the fourth quarter. Pinnacle Financial Partners Inc now owns 11,866 shares of the pharmacy operator’s stock valued at $310,000 after buying an additional 555 shares during the period. Westpac Banking Corp lifted its stake in Walgreens Boots Alliance by 10.1% in the fourth quarter. Westpac Banking Corp now owns 6,100 shares of the pharmacy operator’s stock valued at $159,000 after buying an additional 560 shares during the period. Finally, Massmutual Trust Co. FSB ADV lifted its stake in Walgreens Boots Alliance by 20.6% in the fourth quarter. Massmutual Trust Co. FSB ADV now owns 3,524 shares of the pharmacy operator’s stock valued at $92,000 after buying an additional 602 shares during the period. 58.59% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

WBA has been the topic of several recent analyst reports. Morgan Stanley dropped their price target on Walgreens Boots Alliance from $16.00 to $13.00 and set an “underweight” rating on the stock in a research note on Friday, May 31st. HSBC reissued a “reduce” rating and issued a $20.00 price target (down from $27.00) on shares of Walgreens Boots Alliance in a research note on Tuesday, February 20th. Evercore ISI lowered their target price on Walgreens Boots Alliance from $18.00 to $17.00 and set an “in-line” rating on the stock in a research report on Monday, June 3rd. Bank of America lowered their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating on the stock in a research report on Tuesday, March 26th. Finally, Leerink Partnrs reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Monday, February 26th. Four investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $23.57.

Want More Great Investing Ideas?

Walgreens Boots Alliance Stock Performance

WBA stock opened at $15.55 on Monday. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50. Walgreens Boots Alliance, Inc. has a fifty-two week low of $14.62 and a fifty-two week high of $32.89. The stock has a fifty day moving average of $17.10 and a 200-day moving average of $20.63.

Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) last posted its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, topping the consensus estimate of $0.82 by $0.38. The company had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The firm’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.16 EPS. As a group, sell-side analysts forecast that Walgreens Boots Alliance, Inc. will post 3.21 EPS for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, June 12th. Stockholders of record on Tuesday, May 21st were paid a dividend of $0.25 per share. The ex-dividend date of this dividend was Monday, May 20th. This represents a $1.00 annualized dividend and a dividend yield of 6.43%. Walgreens Boots Alliance’s payout ratio is -14.29%.

Insider Transactions at Walgreens Boots Alliance

In other news, Director Inderpal S. Bhandari purchased 3,000 shares of the business’s stock in a transaction dated Thursday, April 11th. The stock was bought at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the purchase, the director now owns 3,000 shares of the company’s stock, valued at $54,150. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, Director Inderpal S. Bhandari acquired 3,000 shares of the company’s stock in a transaction that occurred on Thursday, April 11th. The shares were acquired at an average price of $18.05 per share, with a total value of $54,150.00. Following the acquisition, the director now owns 3,000 shares of the company’s stock, valued at approximately $54,150. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Manmohan Mahajan acquired 6,000 shares of the company’s stock in a transaction that occurred on Tuesday, April 2nd. The shares were bought at an average cost of $19.38 per share, for a total transaction of $116,280.00. Following the acquisition, the chief financial officer now directly owns 166,969 shares in the company, valued at approximately $3,235,859.22. The disclosure for this purchase can be found here. 17.40% of the stock is owned by corporate insiders.

Walgreens Boots Alliance Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.